Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06929442 · ClinicalTrials.gov registry record · NA

A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

A NA study of Anxiety Disorders and Mood Disorders, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
192
Enrollment target
1
Study location

NCT06929442 is a NA study of Anxiety Disorders and Mood Disorders that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 192 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06929442, a NA study of Anxiety Disorders and Mood Disorders, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
192 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial testing the efficacy of Resilience Training in college students with elevated transdiagnostic risk for developing a serious mental illness.

Interventions

  • BEHAVIORAL Resilience Training (RT)
  • BEHAVIORAL Life Skills Training (LST)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2025-02-10
Est. Completion 2029-06
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06929442

The ClinicalTrials.gov registry entry for NCT06929442 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (83% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Resilience Training (RT) is the first listed.

NCT06929442 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06929442 about?

NCT06929442 is a clinical study titled "A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences". This is a randomized controlled trial testing the efficacy of Resilience Training in college students with elevated transdiagnostic risk for developing a serious mental illness.

What is the current status of trial NCT06929442?

This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2025-02-10. Estimated completion is 2029-06.

What conditions does trial NCT06929442 study?

This clinical trial studies the following conditions: Anxiety Disorders, Mood Disorders, Psychotic Disorders.

What interventions are being tested in trial NCT06929442?

The interventions under investigation include: Resilience Training (RT) (BEHAVIORAL), Life Skills Training (LST) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06929442?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06929442 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.